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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S144then treated with mixed secondary antibodies, Alexa Fluor488 donkey
anti-rabbit IgG and Alexa Fluor594 donkey anti-goat IgG for 30 min.
Results: There were no signiﬁcant differences in the level of HTRA1 mRNA
between control and experimental chondrocytes treated with 42oC, TNFa,
or the high hydrostatic pressure. In contrast, the level of HTRA1 mRNA
increased by w5-fold in human chondrocytes treated with TGF-b1. The
level of HtrA1 mRNA was also increased in mouse chondrocytes treated
with TGF-b1. Expression of p-Smad1 was hardly detected in Col11a1+/-
and DMM mice and corresponding control mice. However, the expression
of Tgf-b1 and p-Smad2 was increased. The increased expression of
p-Smad2 and HtrA1 was co-localized in Col11a1+/- and DMM mice.
Interestingly, expressions of p-Smad2 and HtrA1 were hardly detected in
Col11a1+/- mice treated with the neutralizing TGF-b1 antibody.
Conclusions: These results indicate that TGF-b1 may induce HTRA1 in
chondrocytes. Therefore, current OA therapy using TGF-b1 may be con-
traindicated as it may do more harm than good in the protection of
articular cartilage against OA in matured joints.
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IKKa MODULATES OXIDATIVE STRESS-INDUCED DNA DAMAGE AND
REPAIR IN PRIMARY HUMAN OA CHONDROCYTES
S. Neri 1, S. Guidotti 1, D. Platano 1, E. Olivotto 1, A. Facchini 1,2,
K. Marcu 1,3, R. Borzì 1. 1 Lab. Immunoreumatologia e rigenerazione
tissutale/RAMSES, Istituto Ortopedico Rizzoli, Bologna, Italy; 2Dip. Med.
Clinica, Università di Bologna, Bologna, Italy; 3Biochemistry and Cell
Biology Dept., Stony Brook Univ., Stony Brook, 11794-5215, New York, NY, USA
Purpose: Functional derangement of osteoarthritic chondrocytes make
them more susceptible to stressful conditions such as oxidative stimuli
within aging tissue, which can further provoke extrinsic senescence by
DNA damage responses (DDR). Our previous observation that IKKa
knockdown increased the replicative potential of primary human OA
chondrocyte monolayer cultures and the survival of the same cells
undergoing hypertrophic-like differentiation, prompted us to investigate
whether IKKa knockdown could modulate the stress-induced senescence
of OA chondrocytes as assessed by their DDR.
Methods: We assessed the effects of IKKa loss on ROS-induced DDR by
exposing control and IKKa KD chondrocytes (derived from 10 patients) in
low density in monolayer cultures to 1 hr of 100 mM hydrogen peroxide
and then scored them for their relative degrees of microsatellite instability
(MSI) and double strand breaks (DSB).
Mismatch repair (MMR), the main post-replicative correction pathway has
a fundamental role in maintaining genomic stability and its efﬁciency can
be monitored by assessing MSI. Part of the cells, left untreated or exposed
to 100 mM H2O2, were collected after 6 hour recovery to evaluate MMR
enzymes (i.e., MLH1, MSH2, MSH6, MSH3, PMS1 and PMS2) mRNA
expression by quantitative RT-PCR using GAPDH as a reference control.
Other cells were further cultured for 72 hours and analyzed for MSI at ﬁve
different genomic DNA loci (CD4,VWA, FES, TPOX, and P53).
DDR was evaluated in cells immediately after H2O2 exposure by ﬂow
cytometric analysis for gH2AX foci in chromatin. gH2AX foci serve as
a marker of double strand breaks representing sites of H2AX phosphory-
lation, which can subsequently lead to the recruitment of DNA repair
factors.
Results: Real time PCR data show increased expression of MSH3 and PMS1
mRNAs in IKKa KD chondrocytes after H2O2 exposure. MSI was detected in
control cells but not in their IKKa KD counterparts. Under basal conditions,
preliminary ﬂow cytometry results indicate the comparable presence of
gH2AX DNA foci in IKKa KD and controls in 6 out of 7 patient chondrocytes.
However, after H2O2 exposure, preliminary results indicate a higher
percentage of gH2AX positive cells and more foci per cell in the absence of
IKKa.
Conclusions: Thus far our preliminary data indicate that IKKa controls the
intensity of primary human OA chondrocyte DDR induced by oxidative
stress. Thus IKKa loss appears to increase cell susceptibility to ROS-
mediated DDR as indicated by their augmented DSB induction, perhaps
due in part to the faster doubling time of IKKa deﬁcient cells. However, MSI
and MMR gene expression data suggest that IKKa deﬁcient primary OA
chondrocytes also possess a higher capacity to repair DNA damage. More
experiments are underway to conﬁrm and extend our results with cells atcomparable passage numbers to determine if H2O2-mediated stress
induces these effects or exacerbates a pre-existing physiological state
reﬂecting the faster division rate of IKKa compromised cells.
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AN INVESTIGATION OF THE EFFECT OF EXOGENOUS GROWTH FACTOR
GDF5 ON PRIMARY OA CHONDROCYTES - IS THERE A PREDICTABLE
RESPONSE?
M. Ratnayake 1, F. Plöger 2, M. Santibanez-Koref 1, J. Loughlin 1. 1Newcastle
Univ., Newcastle upon Tyne, United Kingdom; 2Biopharm GmbH, Heidelberg,
Germany
Purpose: A genetic deﬁcit mediated by SNP rs143383 and involving
reduced expression of the growth differentiation factor 5 gene GDF5 is
strongly associated with large-joint OA. We speculated that this deﬁcit
could be attenuated by the application of exogenous GDF5 protein and as
a ﬁrst step we have assessed what effect such application has on primary
OA chondrocyte gene expression.
Methods: Chondrocytes were isolated from the cartilage of OA patients
who had undergone elective surgery of the hip or knee and cultured in the
presence of 100ng/ml of wild-type recombinant human GDF5 protein for
6, 12, 24 and 48 hours. We also studied variants of GDF5 that have a higher
afﬁnity for the BMP Ia receptor, which is highly expressed by chondrocytes.
As a positive control, chondrocytes were treated with TGFb, which is
known to elicit a predictable anti-catabolic response. The expression of
genes coding for catabolic, anti-catabolic, and structural proteins of
cartilage were measured by quantitative PCR (qPCR).
Results: The expression of the relevant GDF5 receptor genes BMPRII,
BMPRIA and BMPRIB was conﬁrmed by qPCR. The capacity of GDF5 to
initiate cell signaling in chondrocytes was demonstrated by the phos-
phorylation of intracellular SMADs, and the ability of the signal to then
translocate to the nucleus was demonstrated by the activation of a lucif-
erase reporter construct harbouring SMAD response elements. Chon-
drocytes cultured with TGFb demonstrated a consistent down-regulation
of the catabolic metalloproteinase genes MMP1 and MMP13, of the carti-
lage differentiation transcription factor gene SOX9, and of the aggrecan
gene ACAN. They also showed a consistent up-regulation of TIMP1, which
codes for an inhibitor of MMPs, and of the cartilage type II collagen gene
COL2A1. In contrast, chondrocytes cultured with wild-type GDF5, or its
variants, did not show any consistent response, with variation observed
relative to the length of time of culture, and with an inconsistent response
between individuals irrespective of the donor's sex or of the original site of
the chondrocytes (hip or knee).
Conclusions: OA chondrocytes do not respond in a predictable manner to
culture with exogenous GDF5. This may be a cause or a consequence of the
OA disease process and will need to be surmounted if treatment with
exogenous GDF5 is going to be advanced as a potential means of alleviating
the genetic deﬁcit mediated by OA susceptibility at the gene GDF5.
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THE ROLE OF NOREPINEPHRINE IN HUMAN ARTICULAR
CHONDROCYTES
J. Kaps 1,2, R.H. Straub 3, M. Böhm4, J. Beckmann 2, J. Grifka 2,
S. Grässel 1,2. 1 Experimental Orthopedics, Ctr. for Med. Biotechnology,
BioPark1, University of Regensburg, Germany; 2Orthopaedic Surgery,
University of Regensburg, Germany; 3Dept. of Internal Med., exp.
Rheumatology and Neuroendocrine-Immunology, University of Regensburg,
Germany; 4Dept. of Dermatology, Lab. for Neuroendocrinology of the Skin
and Interdisciplinary Endocrinology, University of Münster, Germany
Purpose: Norepinephrine belongs to the catecholamine family of tyrosine-
derived neurotransmitters of the sympathetic nervous system. Tyrosine-
hydroxylase positive sympathetic nerve ﬁbers have been identiﬁed in bone
marrow, in the periosteum and in bone-adherent ligaments indicating that
growth and metabolic activity of bone and joint tissues is regulated by
sympathetic neurotransmitter. It is known that norepinephrine can
regulate cell proliferation or apoptosis in several cell types, such as oste-
oblasts. It is further described that norepinephrine modulates inﬂamma-
tion during rheumatoid arthritis and gut inﬂammation. Here, we aim to
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S145understand the role of norepinephrine in human osteoarthritic chon-
drocytes with regard to inﬂammation and its impact on metabolic activity.
Methods: Human chondrocytes were isolated from post-surgery dis-
carded human osteoarthritic articular cartilage. Expression of b2-adren-
ergic receptor on articular cartilage was tested with standard
immunohistochemical analysis. Employing 3D cell cultures in ﬁbringel,
effects of norepinephrine on interleukin-1b induced gene expression of
pro-inﬂammatory cytokines and matrix metalloproteinases (MMP) were
analyzed with quantitative real-time PCR. The impact of norepinephrine
on cell proliferation was determined in monolayer culture with BrdU and
XCelligence analyses.
Results: ß2-adrenergic receptors are abundantly expressed in human
osteoarthritic cartilage. Stimulation with norepinephrine has signiﬁcantly
reduced interleukin-1b induced gene expression of interleukin 8 and
MMP-13 in human osteoarthritic chondrocytes cultured in 3D ﬁbringel.
Notably, we were unable to detect an impact on interleukin-1b induced
gene expression of interleukin-6, MMP-2 and MMP-3. Furthermore,
norepinephrine inhibits BrdU incorporation compared to the controls.
Additionally, we measured a lower cell spreading, assessed through elec-
trical impedance using the XCelligence System (Roche), starting 6 h after
norepinephrine stimulation until analysis was stopped (50 h after stimu-
lation). All effects were observed exclusively with 10-6 M and not with 10-
8 M norepinephrine indicating for a signaling via b-adrenergic receptors.
Conclusions: Neurotransmitters of the sympathetic nervous system like
norepinephrine presumably mediate an anti-inﬂammatory / chon-
droprotective effect in human osteoarthritic chondrocytes via reducing
interleukin-8 and MMP-13. Furthermore, norepinephrine is able to
modulate the metabolic activity by inhibiting cell proliferation of human
osteoarthritic chondrocytes. These ﬁndings indicate, together with b2-
adrenergic receptor expression in human osteoarthritic articular cartilage,
a yet unknown function of catecholaminergic neurotransmitters in adult
human cartilage and might have an impact on osteoarthritis pathology.
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EGR-1 MEDIATES THE SUPPRESSIVE EFFECT OF IL-1 ON PPARG
EXPRESSION IN HUMAN OA CHONDROCYTES
S. Nebbaki, F. El Mansouri, N. Zayed, M. Benderdour, J. Martel-Pelletier,
J.-P. Pelletier, H. Fahmi. Univ. of Montreal, Montreal, QC, Canada
Purpose: PPARg has been shown to down-regulate several inﬂammatory
and catabolic responses in articular cartilage and chondrocytes and to be
protective in animal models of OA. We have previously shown that IL-1
down-regulated PPARg expression in OA chondrocytes. In the present
study we will investigate the mechanisms underlying this effect of IL-1.
Methods: Chondrocytes were stimulated with IL-1, and the level of PPARg
and Egr-1 protein and mRNA were evaluated using Western blotting and
real-time reverse-transcription polymerase chain reaction, respectively.
The PPARg promoter activity was analyzed in transient transfection
experiments. Egr-1 recruitment to the PPARg promoter was evaluated
using chromatin immunoprecipitation (ChIP) assays. Small interfering RNA
(siRNA) approaches were used to silence Egr-1 expression.
Results: We demonstrated that the suppressive effect of IL-1 on PPARg
expression requires de novo protein synthesis and was concomitant with
the induction of the transcription factor Egr-1. ChIP analyses revealed that
IL-1 induced Egr-1 recruitment at the PPARg promoter. IL-1 inhibited the
activity of PPARg promoter and overexpression of Egr-1 potentiated the
inhibitory effect of IL-1, suggesting that Egr-1 maymediate the suppressive
effect of IL-1. Finally, Egr-1 silencing with small interfering RNA blocked
IL-1-mediated down-regulation of PPARg expression.
Conclusion: These results indicate that Egr-1 contributes to IL-1-mediated
down-regulation of PPARg expression in OA chondrocytes and suggest that
this pathway could be a potential target for pharmacologic intervention in
the treatment of OA and possibly other arthritic diseases.
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THE FUNCTIONAL EFFECTS OF DIO2 IN AN IN-VITRO MODEL FOR
CHONDROGENESIS
N. Bömer 1, Y.F. Ramos 1, S.D. Bos 1,2, B.J. Duijnisveld 3, W. Koevoet 4,
G.J. van Osch 4,5, R.G. Nelissen 3, P.E. Slagboom1,2, I. Meulenbelt 1,2. 1Dept.of Molecular Epidemiology, LUMC, Leiden, Netherlands; 2 The Netherlands
Genomics Initiative-sponsored Netherlands Consortium for Hlth.y Aging
(NGI-NCHA), Leiden, Netherlands; 3Dept. of Orthopedics, LUMC, Leiden,
Netherlands; 4Dept. of Otorhinolaryngology, Erasmus MC, Rotterdam,
Netherlands; 5Dept. of Orthopedics, Erasmus MC, Rotterdam, Netherlands
Purpose: Previously, we identiﬁed the deiodinase iodothyronine type-2
gene (DIO2) as a relevant susceptibility gene for osteoarthritis (OA). The
type 2 deiodinase (D2) is a selenoprotein responsible for catalyzing the
conversion of intracellular inactive thyroid (T4) to active thyroid (T3),
a process that occurs in speciﬁc tissues including the growth plate. In the
growth plate, T3 speciﬁcally signals terminal maturation of the chon-
drocytes. Here, we investigate the role of DIO2 during chondrogenesis by
interfering with D2 protein function in an in-vitro chondrogenesis model.
Methods: The ‘RAAK’ study contains human bone marrow derived
mesenchymal stem cells (BM-MSCs) which were isolated from OA affected
hips joints of subjects undergoing total hip arthroplasty. These BM-MSCs
were cultured as micromasses and differentiated into cartilage particles.
First, we assessed expression of DIO2 at consecutive weeks of chondro-
genesis by RT-qPCR on samples previously isolated by the Rotterdam
departments. Next, we tested the RAAK samples for the effect of T3 and
Iodopanoic Acid (IOP), a DIO2 inhibitor, on chondrogenesis by adding them
to the chondrogenic culture medium of the micromass cultures. These
micromass cultures were than maintained up to 49 days. To measure the
effects of interfering with D2 protein function we initially assessed pellet
sizes at different time points and histochemistry with Alcian blue to
determine glycosaminoglycan and Alizarin red to determine calciﬁcations.
Results: DIO2 gene expression signiﬁcantly increased in untreated BM-
MSC micromasses during in-vitro chondrogenesis from 3 weeks onwards
of differentiation. Upon inhibition of DIO2 protein function with IOP, the
BM-MSC micromasses showed no signiﬁcant changes in size after 7 weeks
of differentiationwhen compared to untreated controls. In contrast, excess
of T3 resulted in signiﬁcantly smaller micromasses after 7 weeks of
differentiation suggesting decreased extracellular matrix deposition. This
observation was supported by histological analysis, which showed
decreased Alcian blue staining already after 5 weeks of differentiation in
T3 treated micromasses compared to untreated controls. In addition, only
upon treatment with T3, calcium deposition could be detected by Alizarin
Red staining from 5 weeks of differentiation onwards.
Conclusions: In addition to the association between DIO2 and osteoar-
thritis and the body of literature on the role of DIO2 in endochondral
ossiﬁcation, we are investigating the functional effect of DIO2 on chon-
drogenesis. Our ﬁrst results show a signiﬁcant up-regulation of DIO2 gene
expression during chondrogenic differentiation. Furthermore, we show
that excess T3 in this in-vitro chondrogenesis model, appears to interfere
with the chondrogenesis process reﬂected by signiﬁcant decreased pellet
sizes and decreased Alcian blue staining accompanied by increased
calcium deposition. Currently, we are using both lentiviral-induced DIO2
over expression and siRNA knock-down to explore directly the effect of
DIO2 interference during in-vitro chondrogenesis.
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EXPRESSION OF NUCLEOSTEMIN IN SYNOVIAL TISSUES AND IN
NORMAL AND OSTEOARTHRITIC CHONDROCYTES
M. Ricketts, D.M. Salter, S.H. Ralston. Univ. of Edinburgh, Edinburgh, United
Kingdom
Purpose: Osteoarthritis is a common disease with a strong genetic
component. Despite this, previous attempts to identify genetic variants
that predispose to osteoarthritis have met with limited success. In the past
few months, the results of a large genome wide association study for
osteoarthritis have been reported and identiﬁed a novel susceptibility
locus for the disease on chromosome 3 (Panoutsopoulou et al OARSI 2011).
The strongest association within this region was found with a SNP located
within the coding region of GNL3 gene which encodes nucleostemin
(p¼7.24x10-11). Nucleostemin is a protein that is found within the nucle-
olus of stem cells and tumour cells. It is thought to play a role in regulating
cell cycle progression by modulating the action of p53, but its role in the
joint is unknown. Here we wanted to determine if nucleostemin was
expressed in articular chondrocytes and other joint tissues to determine if
